Endovia Health Sciences, Inc.
PosiFunda Ratios Only on PositoAI
PositoAI's own ratios from Endovia Health Sciences, Inc.'s yearly results (2022–2025), compared with Healthcare companies in United States. Tap ? on any ratio for what it means.
What stands out
- Cash Locked Ratio: Money owed to suppliers is larger than money owed by customers plus stock: $7,527 per $100 of sales comes from others' credit, against $14 tied up three years earlier. Less money tied up than almost all Healthcare companies in United States.
- Cash Cushion Ratio: Debt, after subtracting cash, is 3.9 times its market value (net debt). Lower than almost all Healthcare companies in United States.
Where $100 of sales goes
Latest year (Dec 2025). Taxes and other income are not shown, so the parts need not add up to 100.
Cash quality
Profit Cash Ratio
—Loss-making or profit too small
Over the last 3 years profit was a loss or under 2% of sales, so cash per 100 of profit is not meaningful.
Self-Funding Ratio
—Data incomplete
Cash Locked Ratio
−$7,527Money owed to suppliers is larger than money owed by customers plus stock: $7,527 per $100 of sales comes from others' credit, against $14 tied up three years earlier.
Less money tied up than almost all Healthcare companies in United States.
Growth quality
Steadiness Ratio
1/3 · 1/3Sales grew in 1 of the last 3 years; profit grew in 1 of 3.
Less steady than 70% of Healthcare companies in United States.
Growth Efficiency Ratio
—Sales fell 100%
Sales fell 100% in 3 years, so extra profit per extra sales cannot be measured.
Asset Productivity Ratio
-100% / -94%In 3 years sales changed by -100% while total assets changed by -94%. Assets grew faster than sales.
Balance-sheet strength
Debt Due Cover Ratio
-0.7×Operating cash was negative last year, while some debt falls due within a year.
Higher than 67% of Healthcare companies in United States.
Cash Cushion Ratio
3.9× debtDebt, after subtracting cash, is 3.9 times its market value (net debt).
Lower than almost all Healthcare companies in United States.
Tangible Assets Ratio
—Data incomplete
Tangible Net Worth Ratio
—Data incomplete
Shareholders
Standard fundamentals
P/E, P/B, ROE, debt, growth and more (11)
Endovia Health Sciences, Inc. made a loss over the last year. Endovia Health Sciences, Inc. owes $15.6 for every $1 it owns. Endovia Health Sciences, Inc. made a loss in each of the last two years.
Compared with Healthcare companies in United States · latest annual results Dec 2025.
P/E ratio
LossEndovia Health Sciences, Inc. made a loss over the last year, so its P/E ratio is not meaningful.
P/B ratio
-0.10Endovia Health Sciences, Inc.'s book value is negative (it owes more than it owns), so P/B is not meaningful.
Market cap
$2 MThe total market value of all of Endovia Health Sciences, Inc.'s shares at today's price (share price × number of shares), smaller than almost all Healthcare companies in United States. PosiCap size class: Nano Cap.
Net worth (book value)
NegativeEndovia Health Sciences, Inc.'s net worth is negative ($16 M below zero, balance sheet 30 Jun 2026): it owes more than it owns, so book value per share and P/B are not meaningful.
Owes vs Owns
15.6×Endovia Health Sciences, Inc. owes $15.6 for every $1 it owns, so it owes more than it owns, higher than almost all Healthcare companies in United States.
Dividend yield
NoneEndovia Health Sciences, Inc. does not currently pay a dividend.
Revenue growth
-91%Revenue fell 91% in the year to Dec 2025, and shrank 84% a year on average over 3 years.
Profit growth
LossEndovia Health Sciences, Inc. made a loss in each of the last two years.
Profit margin
-34537.0%Endovia Health Sciences, Inc. lost $34537 for every $100 of revenue.
Interest cover
Not coveredEndovia Health Sciences, Inc.'s operating profit did not cover its interest costs in the year to Dec 2025.
Cash vs debt
Net debtEndovia Health Sciences, Inc. had $6 M more debt than cash (net debt) at Dec 2025.
Questions
How much does Endovia Health Sciences, Inc. owe compared with what it owns?
Endovia Health Sciences, Inc. owes $15.6 for every $1 it owns, so it owes more than it owns, higher than almost all Healthcare companies in United States.
Does Endovia Health Sciences, Inc. pay a dividend?
No. Endovia Health Sciences, Inc. does not currently pay a dividend.
Is Endovia Health Sciences, Inc.'s revenue growing?
Revenue fell 91% in the year to Dec 2025, and shrank 84% a year on average over 3 years.
Figures from the company's yearly results and PositoAI's own data. Full tables are on the Go Deep tab. What each figure means. PositoAI is for research and education only and is not investment advice.